Zobrazeno 1 - 10
of 60
pro vyhledávání: '"Linda H Ficociello"'
Publikováno v:
BMC Nephrology, Vol 25, Iss 1, Pp 1-9 (2024)
Abstract Background Hyperphosphatemia is associated with increased morbidity and mortality in patients with end-stage kidney disease (ESKD). Whereas clinical and observational studies have demonstrated the effectiveness of sucroferric oxyhydroxide (S
Externí odkaz:
https://doaj.org/article/7c199a35c6bc496da5f1a08e75043a98
Autor:
Bruce A Perkins, Naila Rabbani, Andrew Weston, Linda H Ficociello, Antonysunil Adaikalakoteswari, Monika Niewczas, James Warram, Andrzej S Krolewski, Paul Thornalley
Publikováno v:
PLoS ONE, Vol 7, Iss 4, p e35655 (2012)
ObjectiveTo determine the role of markers of plasma protein damage by glycation, oxidation and nitration in microalbuminuria onset or subsequent decline of glomerular filtration rate (termed "early GFR decline") in patients with type 1 diabetes.Metho
Externí odkaz:
https://doaj.org/article/4c707316da3741ce90e5ab3eb0f0d13f
Autor:
Kamyar Kalantar-Zadeh, Linda H. Ficociello, Vidhya Parameswaran, Nicolaos V. Athienites, Claudy Mullon, Robert J. Kossmann, Daniel W. Coyne
Publikováno v:
BMC Nephrology, Vol 20, Iss 1, Pp 1-8 (2019)
Abstract Background Elevated serum phosphorus concentrations are common among maintenance hemodialysis patients. Protein is a major source of dietary phosphate, but restriction of protein intake can result in hypoalbuminemia and protein-energy wastin
Externí odkaz:
https://doaj.org/article/4ed9297a05f64c039d4de6668ebf969a
Autor:
Joanna Willetts, Linda H. Ficociello, Curtis D. Johnson, Sandra E. Alexander, Claudy Mullon, Jeffrey L. Hymes
Publikováno v:
Journal of Nephrology. 36:609-611
Autor:
Denny Treu, Michael Ashenuga, Kara Massingham, James Brugger, Luis Medina, Linda H. Ficociello, David Thompson
Publikováno v:
ASAIO Journal.
Autor:
Linda H Ficociello, Joanna Willetts, Claudy Mullon, Curtis Johnson, Michael S Anger, Jeffrey L Hymes
Publikováno v:
International Journal of Nephrology and Renovascular Disease. 15:319-321
Linda H Ficociello,1 Joanna Willetts,1 Claudy Mullon,1 Curtis Johnson,2 Michael S Anger,1 Jeffrey L Hymes1 1Global Medical Office, Fresenius Medical Care, Waltham, MS, USA; 2Spectra Laboratories, Southaven, MS, USACorrespondence: Jeffrey L Hymes, Fre
Publikováno v:
Seminars in Dialysis. 35:440-445
Hemodiafiltration (HDF) is a renal replacement therapy that utilizes both diffusive clearance and convective transport to achieve greater clearance of middle-molecular-weight solutes. Among other factors, important prerequisites for the implementatio
Autor:
Carsten Hornig, Christian Apel, Linda H. Ficociello, Dana Kendzia, Michael Anger, Sudhir K. Bowry
Publikováno v:
Seminars in Dialysis. 35:405-412
Hemodiafiltration (HDF) achieves a more efficient reduction of the uremic toxic load compared to standard high-flux hemodialysis (HF-HD) by virtue of the combined diffusive and convective clearances of a broad spectrum of uremic retention solutes. Cl
Autor:
Connie M. Rhee, Meijiao Zhou, Rachael Woznick, Claudy Mullon, Michael S. Anger, Linda H. Ficociello
Publikováno v:
International urology and nephrology, vol 55, iss 2
Objective Despite the growing number of elderly hemodialysis patients, the influence of age on nutritional parameters, serum phosphorus (sP), and use of phosphate-binder (PB) medications has not been well characterized. We aimed to describe age-relat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce1ca7560738752c46811bb56095857e
https://escholarship.org/uc/item/7h12f1s3
https://escholarship.org/uc/item/7h12f1s3
Autor:
Linda H. Ficociello, Don Williamson, Michael S. Anger, Meijiao Zhou, Ann Mooney, Claudy Mullon
Publikováno v:
Asaio Journal
Supplemental Digital Content is available in the text.
There is little research on factors that influence the choice of dialyzer in patients undergoing hemodialysis. In patients at risk for poorer outcomes, including those with hypoalbuminemia,
There is little research on factors that influence the choice of dialyzer in patients undergoing hemodialysis. In patients at risk for poorer outcomes, including those with hypoalbuminemia,